{
  "run_id": "RUN_20260204_234342_996d5a3920e1",
  "timestamp": "2026-02-05T03:13:15.099615",
  "document": "Tardive-Dyskinesia.pdf",
  "document_path": "/Users/frederictetard/Projects/ese/gold_data/NLP4RARE/test/Tardive-Dyskinesia.pdf",
  "pipeline_version": "0.8",
  "total_candidates": 2,
  "total_validated": 2,
  "total_rejected": 0,
  "total_investigational": 0,
  "drugs": [
    {
      "matched_text": "prochlorperazine",
      "preferred_name": "prochlorperazine",
      "brand_name": "PROCHLORPERAZINE",
      "compound_id": null,
      "confidence": 0.7,
      "is_investigational": false,
      "drug_class": null,
      "mechanism": null,
      "development_phase": null,
      "sponsor": null,
      "conditions": [],
      "nct_id": null,
      "dosage_form": "SUPPOSITORY",
      "route": "RECTAL",
      "marketing_status": "Discontinued",
      "codes": {
        "rxcui": null,
        "mesh": "D011346",
        "ndc": null,
        "drugbank": null,
        "unii": null
      },
      "all_identifiers": [
        {
          "system": "FDA_NDA",
          "code": "ANDA040407",
          "display": null
        },
        {
          "system": "MeSH",
          "code": "D011346",
          "display": "Prochlorperazine"
        }
      ],
      "context": "euroleptics. Neuroleptic drugs are often prescribed for management of certain mental, neurological, or gastrointestinal disorders. Metoclopramide and prochlorperazine are drugs used for chronic gastrointestinal conditions that may cause tardive dyskinesia. Neuroleptic drugs block dopamine receptors in the brain. Do",
      "page": 1,
      "mention_count": 1,
      "pages_mentioned": [
        1
      ],
      "lexicon_source": "2025_08_fda_approved_drugs.json",
      "validation_flags": [
        "lexicon_match",
        "pubtator_enriched",
        "deduplicated"
      ],
      "mesh_aliases": [],
      "pubtator_normalized_name": "Prochlorperazine",
      "enrichment_source": "pubtator3"
    },
    {
      "matched_text": "Metoclopramide",
      "preferred_name": "Metoclopramide",
      "brand_name": null,
      "compound_id": null,
      "confidence": 0.7,
      "is_investigational": false,
      "drug_class": null,
      "mechanism": null,
      "development_phase": null,
      "sponsor": null,
      "conditions": [],
      "nct_id": null,
      "dosage_form": null,
      "route": null,
      "marketing_status": null,
      "codes": {
        "rxcui": null,
        "mesh": "D008787",
        "ndc": null,
        "drugbank": null,
        "unii": null
      },
      "all_identifiers": [
        {
          "system": "RxCUI",
          "code": "6915",
          "display": null
        },
        {
          "system": "MeSH",
          "code": "D008787",
          "display": "Metoclopramide"
        }
      ],
      "context": "of drugs known as neuroleptics. Neuroleptic drugs are often prescribed for management of certain mental, neurological, or gastrointestinal disorders. Metoclopramide and prochlorperazine are drugs used for chronic gastrointestinal conditions that may cause tardive dyskinesia. Neuroleptic drugs block dopamine recep",
      "page": 1,
      "mention_count": 1,
      "pages_mentioned": [
        1
      ],
      "lexicon_source": "2025_08_lexicon_drug.json",
      "validation_flags": [
        "lexicon_match",
        "pubtator_enriched",
        "deduplicated"
      ],
      "mesh_aliases": [
        "aspirin metoclopramide drug combination"
      ],
      "pubtator_normalized_name": "Metoclopramide",
      "enrichment_source": "pubtator3"
    }
  ]
}